WallStSmart
GALT

Galectin Therapeutics Inc

NASDAQ: GALT · HEALTHCARE · BIOTECHNOLOGY

$2.27
+0.89% today

Updated 2026-04-30

Market cap
$156.01M
P/E ratio
P/S ratio
EPS (TTM)
$-0.48
Dividend yield
52W range
$1 – $7
Volume
0.3M

Galectin Therapeutics Inc (GALT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+57.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.5%
2026-03-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-26$-0.08+20.0%$2.93$2.68-8.5%
2025-11-14$-0.13+27.8%$5.53$6.00+8.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$-0.08+20.0%
2025-09-30$-0.18$-0.13+27.8%
2025-06-30$-0.19$-0.12+36.8%
2025-03-31$-0.11$-0.19-74.3%
2024-12-31$-0.16$-0.19-18.8%$36000.00-55.0%
2024-09-30$-0.20$-0.18+10.0%
2024-06-30$-0.16$-0.20-25.0%
2024-03-31$-0.16$-0.19-18.8%
2023-12-31$-0.16$-0.16+0.0%$80000.00
2023-09-30$-0.16$-0.24-50.0%
2023-06-30$-0.21$-0.15+28.6%
2023-03-31$-0.21$-0.19+9.5%
2022-12-31$-0.17$-0.18-5.9%

Frequently asked questions

Has Galectin Therapeutics Inc beaten earnings estimates?
Galectin Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +2.6% over the last 4 quarters.
How does GALT stock react to earnings?
GALT stock has moved an average of -0.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.